Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Takahashi, Masato"" wg kryterium: Autor


Tytuł:
Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region
Autorzy:
Tomioka, NobumotoAff1, IDs12282023014429_cor1
Hatanaka, Kanako C.
Okuyama, Dai
Watanabe, Ken-ichi
Yamamoto, Mitsugu
Maeda, Hideki
Tachikawa, Hanae
Kuwahara, Sayuri
Shimizu, Ai
Suzuki, Hiroaki
Hatanaka, YutakaAff2, Aff5
Takahashi, Masato
Pokaż więcej
Źródło:
Breast Cancer. 30(3):497-505
Czasopismo naukowe
Tytuł:
Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region
Autorzy:
Tomioka, NobumotoAff1, IDs12282023014545_cor1
Hatanaka, Kanako C.
Okuyama, Dai
Watanabe, Ken-ichi
Yamamoto, Mitsugu
Maeda, Hideki
Tachikawa, Hanae
Kuwahara, Sayuri
Shimizu, Ai
Suzuki, Hiroaki
Hatanaka, YutakaAff2, Aff5
Takahashi, Masato
Pokaż więcej
Źródło:
Breast Cancer. 30(4):689-690
Czasopismo naukowe
Tytuł:
Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study
Autorzy:
Kotani, HaruruAff1, IDs1228202201390w_cor1
Masuda, NorikazuAff2, Aff10
Yamashita, Toshinari
Naito, Yoichi
Taira, Tetsuhiko
Inoue, Kenichi
Takahashi, Masato
Yonemori, Kan
Toyoizumi, Shigeyuki
Mori, Yuko
Nagasawa, Takashi
Hori, Natsuki
Iwata, Hiroji
Pokaż więcej
Źródło:
Breast Cancer. 29(6):1088-1098
Czasopismo naukowe
Tytuł:
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Autorzy:
Takahashi, Masato
Tokunaga, Eriko
Mori, Joji
Tanizawa, Yoshinori
van der Walt, Jan-Stefan
Kawaguchi, Tsutomu
Goetz, Matthew P.
Toi, MasakazuAff6, IDs12282021012950_cor8
Pokaż więcej
Źródło:
Breast Cancer. 29(1):174-184
Czasopismo naukowe
Tytuł:
Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer
Autorzy:
Taira, NarutoAff1, IDs12282021012905_cor1
Kashiwabara, Kosuke
Tsurutani, Junji
Kitada, Masahiro
Takahashi, Masato
Kato, Hiroaki
Kikawa, Yuichiro
Sakata, Eiko
Naito, Yoichi
Hasegawa, Yoshie
Saito, Tsuyoshi
Iwasa, Tsutomu
Takashima, Tsutomu
Aihara, Tomohiko
Mukai, Hirofumi
Hara, Fumikata
Pokaż więcej
Źródło:
Breast Cancer. 29(1):131-143
Czasopismo naukowe
Tytuł:
Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study
Autorzy:
Koh, Su-JinAff1, IDs12282021012834_cor1
Ohsumi, Shozo
Takahashi, Masato
Fukuma, Eisuke
Jung, Kyung Hae
Ishida, Takanori
Dai, Ming-Shen
Chang, Chuan-Hsun
Dalvi, Tapashi
Walker, Graham
Bennett, James
O’Shaughnessy, Joyce
Balmaña, Judith
Pokaż więcej
Źródło:
Breast Cancer. 29(1):92-102
Czasopismo naukowe
Tytuł:
Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer
Autorzy:
Taira, NarutoAff1, IDs1228202101296z_cor1
Kashiwabara, Kosuke
Tsurutani, Junji
Kitada, Masahiro
Takahashi, Masato
Kato, Hiroaki
Kikawa, Yuichiro
Sakata, Eiko
Naito, Yoichi
Hasegawa, Yoshie
Saito, Tsuyoshi
Iwasa, Tsutomu
Takashima, Tsutomu
Aihara, Tomohiko
Mukai, Hirofumi
Hara, Fumikata
Pokaż więcej
Źródło:
Breast Cancer. 29(1):186-188
Czasopismo naukowe
Tytuł:
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy
Autorzy:
Inoue, Kenichi
Masuda, Norikazu
Iwata, Hiroji
Takahashi, Masato
Ito, Yoshinori
Miyoshi, Yasuo
Nakayama, Takahiro
Mukai, Hirofumi
van der Walt, Jan-Stefan
Mori, Joji
Sakaguchi, Sachi
Kawaguchi, Tsutomu
Tanizawa, Yoshinori
Llombart-Cussac, AntonioAff11, Aff12
Sledge, Jr, George W.
Toi, Masakazu
Pokaż więcej
Źródło:
Breast Cancer. 28(5):1038-1050
Czasopismo naukowe
Tytuł:
Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study
Autorzy:
Yamamoto, Yutaka
Yamashiro, Hiroyasu
Toh, Uhi
Kondo, NaotoAff4, Aff5
Nakamura, Rikiya
Kashiwaba, Masahiro
Takahashi, Masato
Tsugawa, Koichiro
Ishikawa, Takashi
Nakayama, Takahiro
Ohtani, Shoichiro
Takano, Toshimi
Fujisawa, Tomomi
Toyama, Tatsuya
Kawaguchi, Hidetoshi
Mashino, Kojiro
Tanino, Yuichi
Morita, Satoshi
Toi, Masakazu
Ohno, Shinji
Pokaż więcej
Źródło:
Breast Cancer. 28(1):145-160
Czasopismo naukowe
Tytuł:
Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study
Autorzy:
Koh, Su-JinAff1, IDs1228202101299w_cor1
Ohsumi, Shozo
Takahashi, Masato
Fukuma, Eisuke
Jung, Kyung Hae
Ishida, Takanori
Dai, Ming-Shen
Chang, Chuan-Hsun
Dalvi, Tapashi
Walker, Graham
Bennett, James
O’Shaughnessy, Joyce
Balmaña, Judith
Pokaż więcej
Źródło:
Breast Cancer. 29(1):189-190
Czasopismo naukowe
Tytuł:
The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs
Autorzy:
Iwamoto, Takayuki
Fujisawa, Tomomi
Shien, Tadahiko
Araki, Kazuhiro
Sakamaki, Kentaro
Sangai, Takafumi
Kikawa, Yuichiro
Takao, Shintaro
Nishimura, Reiki
Takahashi, Masato
Aihara, Tomohiko
Mukai, Hirofumi
Taira, Naruto
Pokaż więcej
Źródło:
Breast Cancer. 27(5):973-981
Czasopismo naukowe
Tytuł:
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition
Autorzy:
Shimoi, TatsunoriAff1, Aff23
Nagai, Shigenori E.Aff2, Aff23
Yoshinami, TetsuhiroAff3, Aff23
Takahashi, MasatoAff4, Aff23
Arioka, HitoshiAff5, Aff23
Ishihara, MikiyaAff6, Aff23
Kikawa, YuichiroAff7, Aff23
Koizumi, KeiAff8, Aff23
Kondo, NaotoAff9, Aff23
Sagara, YasuakiAff10, Aff23
Takada, MasahiroAff11, Aff23
Takano, ToshimiAff12, Aff23
Tsurutani, JunjiAff13, Aff23
Naito, YoichiAff14, Aff23
Nakamura, RikiyaAff15, Aff23
Hattori, MasayaAff16, Aff23
Hara, FimikataAff17, Aff23
Hayashi, NaokiAff18, Aff23
Mizuno, ToshiroAff6, Aff23
Miyashita, MinoruAff19, Aff23
Yamashita, NamiAff20, Aff23
Yamanaka, TakashiAff21, Aff23
Saji, ShigehiraAff22, Aff23
Iwata, HirojiAff16, Aff23
Toyama, TatsuyaAff9, Aff23
Pokaż więcej
Źródło:
Breast Cancer. 27(3):322-331
Czasopismo naukowe
Tytuł:
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition
Autorzy:
Shimoi, TatsunoriAff1, Aff23
Nagai, Shigenori E.Aff2, Aff23
Yoshinami, TetsuhiroAff3, Aff23
Takahashi, MasatoAff4, Aff23
Arioka, HitoshiAff5, Aff23
Ishihara, MikiyaAff6, Aff23
Kikawa, YuichiroAff7, Aff23
Koizumi, KeiAff8, Aff23
Kondo, NaotoAff9, Aff23
Sagara, YasuakiAff10, Aff23
Takada, MasahiroAff11, Aff23
Takano, ToshimiAff12, Aff23
Tsurutani, JunjiAff13, Aff23
Naito, YoichiAff14, Aff23
Nakamura, RikiyaAff15, Aff23
Hattori, MasayaAff16, Aff23
Hara, FimikataAff17, Aff23
Hayashi, NaokiAff18, Aff23
Mizuno, ToshiroAff6, Aff23
Miyashita, MinoruAff19, Aff23
Yamashita, NamiAff20, Aff23
Yamanaka, TakashiAff21, Aff23
Saji, ShigehiraAff22, Aff23
Iwata, HirojiAff16, Aff23
Toyama, TatsuyaAff9, Aff23
Pokaż więcej
Źródło:
Breast Cancer. 28(4):985-986
Czasopismo naukowe
Tytuł:
Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)
Autorzy:
Ohtani, Shoichiro
Nakayama, Takahiro
Yoshinami, Tetsuhiro
Watanabe, Ken-ichi
Hara, Fumikata
Sagara, Yasuaki
Kawaguchi, Hidetoshi
Higaki, Kenji
Matsunami, Nobuki
Hasegawa, Yoshie
Takahashi, Masato
Mizutani, Makiko
Morimoto, Takashi
Sato, Masako
Itoh, Mitsuya
Morita, Satoshi
Masuda, Norikazu
Pokaż więcej
Źródło:
Breast Cancer. 25(4):438-446
Czasopismo naukowe
Tytuł:
Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer
Autorzy:
Ogiya, Akiko
Yamazaki, Kieko
Horii, Rie
Shien, Tadahiko
Horimoto, Yoshiya
Masuda, Norikazu
Inao, Touko
Hosoda, Mitsuchika
Ishida, Naoko
Osako, Tomofumi
Takahashi, Masato
Endo, Yumi
Miyoshi, Yuichiro
Yasojima, Hiroyuki
Tomioka, Nobumoto
Yamashita, Hiroko
Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society
Pokaż więcej
Źródło:
Breast Cancer. May 2017 24(3):473-482
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies